Genotype-guided fluoropyrimidine dosing: ready for implementation.

Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2018). Genotype-guided fluoropyrimidine dosing: ready for implementation. The lancet oncology, 19(11), pp. 1421-1422. Elsevier 10.1016/S1470-2045(18)30744-7

[img] Text
1-s2.0-S1470204518307447-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (136kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry

UniBE Contributor:

Amstutz, Ursula and Largiadèr, Carlo Rodolfo

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1474-5488

Publisher:

Elsevier

Language:

English

Submitter:

Marie-Christine Müller

Date Deposited:

06 Feb 2019 14:43

Last Modified:

12 Dec 2019 03:13

Publisher DOI:

10.1016/S1470-2045(18)30744-7

PubMed ID:

30348539

BORIS DOI:

10.7892/boris.125807

URI:

https://boris.unibe.ch/id/eprint/125807

Actions (login required)

Edit item Edit item
Provide Feedback